Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,262
datasets available to search
ShareScore release 0.9.0
Dataset results
6,262 results for “Treatment efficacy”
Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders
ClinicalTrials.gov study NCT00992459. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Includi
ClinicalTrials.gov study NCT01998841. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
ClinicalTrials.gov study NCT02621892. IPD Sharing: Not stated. Countries: 1. Publications: 4.
24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms
ClinicalTrials.gov study NCT01101841. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)
ClinicalTrials.gov study NCT06637683. IPD Sharing: YES. Countries: 1. Publications: 7.
Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma
ClinicalTrials.gov study NCT02211131. IPD Sharing: YES. Countries: 9. Publications: 2.
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis
ClinicalTrials.gov study NCT01201798. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
ClinicalTrials.gov study NCT01240902. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea
ClinicalTrials.gov study NCT01130272. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
ClinicalTrials.gov study NCT03721172. IPD Sharing: YES. Countries: 2. Publications: 2.
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Anti
ClinicalTrials.gov study NCT01519791. IPD Sharing: Not stated. Countries: 22. Publications: 2.
A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1
ClinicalTrials.gov study NCT03227861. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoie
ClinicalTrials.gov study NCT03246529. IPD Sharing: NO. Countries: 5. Publications: 2.
A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee
ClinicalTrials.gov study NCT00379236. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
ClinicalTrials.gov study NCT02076412. IPD Sharing: NO. Countries: 9. Publications: 1.
Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria
ClinicalTrials.gov study NCT03580044. IPD Sharing: YES. Countries: 12. Publications: 3.
An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.
ClinicalTrials.gov study NCT03312634. IPD Sharing: UNDECIDED. Countries: 11. Publications: 3.
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00511706. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa
ClinicalTrials.gov study NCT02644525. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
ClinicalTrials.gov study NCT00597584. IPD Sharing: Not stated. Countries: 9. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.